7 results on '"Cuny, Damien"'
Search Results
2. Polypharmacy in older patients: identifying the need for support by a community pharmacist
- Author
-
Beuscart, Jean-Baptiste, Petit, Ségolène, Gautier, Sophie, Wierre, Patrick, Balcaen, Thibaut, Lefebvre, Jean-Marc, Kambia, Nicolas, Bertoux, Elisabeth, Mascaut, Daniel, Barthélémy, Christine, Cuny, Damien, Puisieux, François, Décaudin, Bertrand, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Troubles cognitifs dégénératifs et vasculaires - U 1171 (TCDV), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Lille 2 - Faculté de Médecine, Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université de Lille, Impact de l'environnement chimique sur la santé humaine - ULR 4483 (IMPECS), Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 (TCDV), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Faculté de Médecine Henri Warembourg - Université de Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Troubles cognitifs dégénératifs et vasculaires - U1171, Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV], Institut d'Électronique, de Microélectronique et de Nanotechnologie (IEMN) - UMR 8520, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], IMPact de l'Environnement Chimique sur la Santé humaine (IMPECS) - EA 4483, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], Institut d’Électronique, de Microélectronique et de Nanotechnologie - UMR 8520 [IEMN], Impact de l'environnement chimique sur la santé humaine - ULR 4483 [IMPECS], and Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
- Subjects
Aged, 80 and over ,Male ,[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology ,education ,Community Pharmacy Services ,lcsh:Geriatrics ,Pharmacists ,lcsh:RC952-954.6 ,Cross-Sectional Studies ,Medication Reconciliation ,Polypharmacy ,Humans ,Female ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,France ,Potentially Inappropriate Medication List ,Research Article ,Aged - Abstract
International audience; BACKGROUND: The community pharmacist is a key player in medication reviews of older outpatients. However, it is not always clear which individuals require a medication review. The objective of the present study was to identify high-priority older patients for intervention by a community pharmacist.METHODS: As part of their final-year placement in a community pharmacy, pharmacy students conducted 10 interviews each with older adults (aged 65 or over) taking at least five medications daily. The student interviewer also offered to examine the patient's home medicine cabinet. An interview guide was developed by an expert group to assess the difficulties in managing and taking medications encountered by older patients.RESULTS: The 141 students interviewed a total of 1370 patients (mean age: 81.5; mean number of medications taken daily: 9.3). Of the 1370 interviews, 743 (54.2%) were performed in the patient's home, and thus also included an examination of the home medicine cabinet. Adverse events were reported by 566 (42.0%) patients. A total of 378 patients (27.6%) reported difficulties in preparing, administering and/or swallowing medications. The inspections of medicine cabinets identified a variety of shortcomings: poorly located cabinets (in 15.0% of inspections), medication storage problems (21.7%), expired medications (40.7%), potentially inappropriate medications (15.0%), several different generic versions of the same drug (19.9%), and redundant medications (20.4%).CONCLUSIONS: In a community pharmacy setting, high-priority older patients for intervention by a community pharmacist can be identified by asking simple questions about difficulties in managing, administering, taking or storing medications.
- Published
- 2019
- Full Text
- View/download PDF
3. MOESM2 of Polypharmacy in older patients: identifying the need for support by a community pharmacist
- Author
-
Jean-Baptiste Beuscart, Petit, Ségolène, Gautier, Sophie, Wierre, Patrick, Balcaen, Thibaut, Jean-Marc Lefebvre, Kambia, Nicolas, Bertoux, Elisabeth, Mascaut, Daniel, Barthélémy, Christine, Cuny, Damien, Puisieux, François, and Décaudin, Bertrand
- Abstract
Additional file 2. Topic guide for the medicine cabinet inspection.
- Published
- 2019
- Full Text
- View/download PDF
4. MOESM1 of Polypharmacy in older patients: identifying the need for support by a community pharmacist
- Author
-
Jean-Baptiste Beuscart, Petit, Ségolène, Gautier, Sophie, Wierre, Patrick, Balcaen, Thibaut, Jean-Marc Lefebvre, Kambia, Nicolas, Bertoux, Elisabeth, Mascaut, Daniel, Barthélémy, Christine, Cuny, Damien, Puisieux, François, and Décaudin, Bertrand
- Abstract
Additional file 1. Topic guide for the management of personal treatment and side-effects.
- Published
- 2019
- Full Text
- View/download PDF
5. Development and Evaluation of a Hybrid Course in Clinical Virology at a Faculty of Pharmacy in Lille, France (Preprint)
- Author
-
Anne Goffard, Pascal Odou, El Moukhtar Aliouat, Cécile-Marie Aliouat-Denis, Christophe Carnoy, Bertrand Décaudin, Cuny Damien, Mounira Hamoudi, Claire Pinçon, Katia Quelennec, Sebastien Zanetti, Pierre Ravaux, and Annie Standaert
- Subjects
ComputingMilieux_COMPUTERSANDEDUCATION - Abstract
BACKGROUND During their studies, pharmacy students must acquire the specific skills in clinical virology required for their subsequent professional practice. Recent experiments on teaching and learning in higher education have shown that hybrid courses strengthen the students’ commitment to learning and enable high-quality knowledge acquisition. OBJECTIVE This study concerned the design and deployment of a hybrid course that combines face-to-face and Web-based instruction in clinical virology for fourth-year pharmacy students. The study’s objectives were to (1) measure the students’ level of involvement in the course, (2) gauge their interest in this type of learning, and (3) highlight any associated difficulties. METHODS The study included 194 fourth-year pharmacy students from the Lille Faculty of Pharmacy (University of Lille, Lille, France) between January and June 2017. The students followed a hybrid course comprising an online learning module and 5 tutorial sessions in which professional situations were simulated. The learning module and 3 online evaluation sessions were delivered via the Moodle learning management system. Each tutorial session ended with an evaluation. The number of Moodle log-ins, the number of views of learning resources, and the evaluation marks were recorded. The coefficient for the correlation between the marks in the online evaluation and those in the tutorials was calculated. The students’ opinions and level of satisfaction were evaluated via a course questionnaire. RESULTS The course’s learning resources and Web pages were viewed 21,446 and 3413 times, respectively. Of the 194 students, 188 (96.9%) passed the course (ie, marks of at least 10 out of 20). There was a satisfactory correlation between the marks obtained in the online evaluations and those obtained after the tutorials. The course met the students’ expectations in 53.2% of cases, and 57.4% of the students stated that they were able to work at their own pace. Finally, 26.6% of the students stated that they had difficulty organizing their work around this hybrid course. CONCLUSIONS Our results showed that pharmacy students were strongly in favor of a hybrid course. The levels of attendance and participation were high. However, teachers must be aware that some students will encounter organizational difficulties.
- Published
- 2018
- Full Text
- View/download PDF
6. [Community pharmacists' interventions to prevent and screen chronic kidney disease patients]
- Author
-
Belaiche, Stéphanie, Mercier, Edwige, Cuny, Damien, Kambia, Nicolas, Wierre, Patrick, Bertoux, Elisabeth, Mascaut, Daniel, Azar, Raymond, Bataille, Pierre, Bourdon, Franck, Mac Namara, Evelyne, Maisonneuve, Nathalie, Painchart, Bernard, Vrigneau, Laurence, Noel, Christian, Decaudin, Bertrand, Glowacki, Francois, Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Impact de l'environnement chimique sur la santé humaine - ULR 4483 (IMPECS), Université de Lille, Centre hospitalier [Valenciennes, Nord], Centre Hospitalier [Douai, Nord], Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, and Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
- Subjects
Male ,Prevention ,[SDV]Life Sciences [q-bio] ,Pharmacists ,Chronic kidney disease ,Humans ,Mass Screening ,Pharmacist intervention ,Female ,France ,Prospective Studies ,Renal Insufficiency, Chronic ,Aged ,Glomerular Filtration Rate - Abstract
International audience; Chronic kidney disease (CKD) is a major concern of public health. The pharmacist is known as a health practitioner involved in prevention and therapeutic education. Our study aimed at defining the impact of community pharmacists' interventions for preventing and screening CKD. In our observational prospective study of 5 months conducted in 109 community pharmacy, we included 2 groups of patients: A (therapeutic optimization): CKD patients and B (CKD screening): population at risk. In group A, we included 354 patients, mainly women (51.2%), in stage 3 of CKD, mean age 73 years old, with hypertension alone (40.6%) or associated with diabetes (44%). About 70% of the patients had a follow up by a nephrologist and 45% of them were good adherent according to the Morisky-Green self-report. However, approximately 20% of patients did not have nephroprotective treatments in their regimen although they were on stage 3 or 4 CKD patients, and about half of them were not aware of medical situations at risk. Concerning group B, 532 patients were included. The pharmaceutical interventions screened 10% of patients with a GFR
- Published
- 2016
- Full Text
- View/download PDF
7. A SPATIAL CLUSTER DETECTION OF CHRONIC KIDNEY DISEASE: RELATION TO DEPRIVATION AT SMALL SCALE
- Author
-
Occelli, Florent, Michael Genin, Deram, Annabelle, Glowacki, Francois, Cuny, Damien, and Nephronor Network
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.